Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Published: Oct, 2015 | Pages: 45 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Quark Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Quark Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Quark Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Quark Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Quark Pharmaceuticals, Inc.'s pipeline products

Reasons to Buy

- Evaluate Quark Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Quark Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Quark Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Quark Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quark Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Quark Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents
 2
List of Tables 5
List of Figures 5
Quark Pharmaceuticals, Inc. Snapshot 6
Quark Pharmaceuticals, Inc. Overview 6
Key Information 6
Key Facts 6
Quark Pharmaceuticals, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Quark Pharmaceuticals, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Quark Pharmaceuticals, Inc. - Pipeline Products Glance 14
Quark Pharmaceuticals, Inc. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Quark Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Quark Pharmaceuticals, Inc. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Quark Pharmaceuticals, Inc. - Drug Profiles 18
QPI-1002 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
QPI-1007 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PF-655 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
QPHL-2 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
QPLI-1 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
QPAL-1 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
QPAL-2 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
QPCO-1 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
QPCP-1 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
QPEN-1 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
QPEN-2 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
QPHL-1 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
QPHL-3 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
QPLI-2 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
QPNR-1 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Quark Pharmaceuticals, Inc. - Pipeline Analysis 36
Quark Pharmaceuticals, Inc. - Pipeline Products by Target 36
Quark Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 37
Quark Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 38
Quark Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 39
Quark Pharmaceuticals, Inc. - Recent Pipeline Updates 40
Quark Pharmaceuticals, Inc. - Dormant Projects 42
Quark Pharmaceuticals, Inc. - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45

List of Tables

Quark Pharmaceuticals, Inc., Key Information 6
Quark Pharmaceuticals, Inc., Key Facts 6
Quark Pharmaceuticals, Inc. - Pipeline by Indication, 2015 8
Quark Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 10
Quark Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 11
Quark Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015 12
Quark Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015 13
Quark Pharmaceuticals, Inc. - Phase III, 2015 14
Quark Pharmaceuticals, Inc. - Phase II, 2015 15
Quark Pharmaceuticals, Inc. - Preclinical, 2015 16
Quark Pharmaceuticals, Inc. - Discovery, 2015 17
Quark Pharmaceuticals, Inc. - Pipeline by Target, 2015 36
Quark Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 37
Quark Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 38
Quark Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 39
Quark Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 40
Quark Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 42
Quark Pharmaceuticals, Inc., Other Locations 43